Amyloid Solution

Amyloid Solution is a biotechnology company focused on developing innovative treatments for Alzheimer's disease. The company operates in the healthcare and pharmaceutical market, targeting patients at various stages of Alzheimer's with diverse pathological alterations. Amyloid Solution's business model revolves around research and development (R&D) of disease-modifying therapies, leveraging both domestic and international collaborations with key scientists and biopharma industries. The company generates revenue through investment rounds and partnerships, having raised significant funds from programs like TIPS and investors such as POSCO CAPITAL and KB Investment. Amyloid Solution also acquired Deargen, an AI-based drug development company, to enhance its R&D capabilities. The company aims to provide effective, safe, and diverse therapeutic solutions to combat Alzheimer's disease.

Keywords: Alzheimer's, biotechnology, R&D, therapeutic solutions, biopharma, investment, AI drug development, healthcare, pharmaceutical, innovation.